# A Study to Assess the Effect of AZD0780 on Ambulatory Blood Pressure

Study · id `cardio:ct-nct06692764` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06692764](<https://clinicaltrials.gov/study/NCT06692764>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT06692764

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 202 participants.

## Technical summary

Registry record NCT06692764. Randomized; triple masking; primary purpose treatment. Start 2024-10-30 (actual); primary completion 2025-04-18 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 202 participants (enrolled count; ClinicalTrials.gov record NCT06692764, source copy `cardio:ctgov-nct06692764-2026-02-18`, retrieved 2026-10-31)
- Started: 2024-10-30 (actual) (ClinicalTrials.gov record NCT06692764, source copy `cardio:ctgov-nct06692764-2026-02-18`, retrieved 2026-10-31)
- Primary completion: 2025-04-18 (actual) (ClinicalTrials.gov record NCT06692764, source copy `cardio:ctgov-nct06692764-2026-02-18`, retrieved 2026-10-31)
- Completion: 2025-05-02 (actual) (ClinicalTrials.gov record NCT06692764, source copy `cardio:ctgov-nct06692764-2026-02-18`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT06692764, source copy `cardio:ctgov-nct06692764-2026-02-18`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06692764-2026-02-18`, retrieved 2026-10-31)

## The registry's words

- Brief title: A Study to Assess the Effect of AZD0780 on Ambulatory Blood Pressure
- Acronym: AZD0780-ABPM
- Condition: Atherosclerotic Cardiovascular Disease
- Intervention (Drug): Placebo
- Intervention (Drug): AZD0780
- Lead sponsor: AstraZeneca
- Lead sponsor class: INDUSTRY
- Collaborator: Fortrea
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry lists this organization as the lead sponsor: AstraZeneca (`cardio:astrazeneca`)
- Registry lists this organization as a collaborator: Fortrea (`cardio:org-fortrea`)

## Provenance

Content hash: 5294e37b02c8eb7b98d8219976a292d06da5e97fbd0a88ee0c7b18126c0658b2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
